This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 27
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study aimed to evaluate the safety and reactogenicity of two intramuscular injections of two different dosages of an investigational clade B HIV vaccine.

Provided treatments

  • Biological: Investigational HIV vaccine dose A
  • Biological: Investigational HIV vaccine dose B

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320176. The sponsor of the trial is Institut Pasteur and it is looking for 36 volunteers for the current phase.
Official trial title:
An Open-label, Phase I, Dose-escalation and Safety Study of Two Intramuscular Injections of a Dose of 2.9 Log or 4 Log CCID50 of the Recombinant HIV I Clade B Measles Vaccine Vector in Healthy Adults.